IBRX
IMMUNITYBIO INC
Health Care·Biotechnology·UNITED STATES
$7.84
MCap $8.3B
as of 2026-08-20
Total
C1w
Fund
C9w
Quant
C1w
Price
▲ Up▼ Down━ MA30━ MA100━ Mean┄ U┄ L
MIDOS % pane · green > 90 long zone · red < 10 short zone · reference lines at 10 / 90
MIDOS SI
as of 2026-08-20
MIDOS SI
-0.51
Sentiment 81.6%
−3 oversold0+3 overbought
Signal
NEUTRAL
Actual
$7.84
Adaptive Mean
$7.96
-0.12 vs mean
Adaptive σ
0.11
MIDOS BB
$7.73 – $8.18
center ± 2σ adaptive
Fundamental Factors (Sector-Relative Z)
as of 2026-08-21
Composite Z
-0.73
ROE
—
Z —
Rev Gr
93.9%
Z +1.11
EPS Gr
—
Z +0.07
OPM Gr
149.4%
Z +0.05
FCF Yld
-2.2%
Z -0.15
EPS Surp
-1.8%
Z -5.64
EPS 3mo Δ
28.6%
Z +0.16
Fwd P/E
-62.40
Z —
PEGY
N/A
growth + yield ≤ 0
Momentum (Risk-Adjusted Alpha)
as of 2026-08-21
Q3M
-0.25
Q6M
-0.96
Q12M
8.30
MA 30/100
0.986
Bearish (MA30 < MA100)
α (Jensen)
-0.0278
β (12M)
1.67
σ (12M)
1.042
Divergence — Fundamentals vs Momentum
Z Percentile
6%
Q Percentile
93%
Divergence
-87.0
Tier
TRIM — ACT
Momentum well ahead of fundamentals. Trim candidate.
Kirkpatrick RS & Persistence
RS
19.7
RS Pctl
81%
RS Decile
D9
Persistence
1w
at grade C
Options / OI Analysis
No options or Williams data available for this ticker.